OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00281258

Yunnan Energy New Material (Group) Co Ltd

Commodity ChemicalsVerified

The company's capital structure is moderately leveraged, with a debt-to-equity ratio of 0.63, indicating a balanced mix of debt and equity financing. However, its liquidity position is constrained, as evidenced by a negative net cash position when total debt is subtracted. Free cash flow for the latest period was 253.21 million CNY, but this is significantly lower than capital expenditures, which were -1.73 billion CNY, suggesting a heavy investment in long-term assets. Profitability metrics are weak compared to industry norms. Return on equity (ROE) is 0.56%, and return on assets (ROA) is 0.29%, both of which are below the typical thresholds for healthy performance in the commodity chemicals sector. The company's operating margin is 3.28% (calculated from operating income of 447.64 million CNY on revenue of 13.63 billion CNY), which is also below the median for the industry. Geographically, the company is concentrated in China, with no disclosed international revenue segments. Its revenue is primarily derived from a single business line, commodity chemicals, which exposes it to commodity price volatility and cyclical demand. The lack of diversification increases its vulnerability to sector-specific downturns. Looking ahead, the company is expected to see modest revenue growth, though the exact magnitude is not specified. Capital expenditures are expected to remain high, which may continue to pressure free cash flow. The company's operating cash flow of 1.14 billion CNY provides some buffer, but it is not sufficient to cover the large capital outlay. The risk assessment highlights liquidity as a medium concern, with the company's cash and equivalents at just 4.16 million CNY, far below the level needed to cover short-term obligations. The risk of dilution is currently low, but the company's capital structure includes long-term debt of 16.15 billion CNY, which could necessitate future equity issuance if debt service becomes burdensome. Recent filings and transcripts have not revealed any major strategic shifts or operational disruptions. The company remains focused on its core chemical production business, with no significant new product launches or market expansions disclosed in the latest available data.

30-day price · 002812+6.49 (+9.3%)
Low$65.13High$87.71Close$76.28As of22 May, 00:00 UTC
Profile
CompanyYunnan Energy New Material (Group) Co Ltd
Ticker002812.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Yunnan Energy New Material (Group) Co Ltd is a Chinese chemical manufacturing company that produces and sells commodity chemicals, primarily generating revenue through the sale of chemical products to industrial and manufacturing customers.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92 based on verified market data.

The company's capital structure is moderately leveraged, with a debt-to-equity ratio of 0.63, indicating a balanced mix of debt and equity financing. However, its liquidity position is constrained, as evidenced by a negative net cash position when total debt is subtracted. Free cash flow for the latest period was 253.21 million CNY, but this is significantly lower than capital expenditures, which were -1.73 billion CNY, suggesting a heavy investment in long-term assets. Profitability metrics are weak compared to industry norms. Return on equity (ROE) is 0.56%, and return on assets (ROA) is 0.29%, both of which are below the typical thresholds for healthy performance in the commodity chemicals sector. The company's operating margin is 3.28% (calculated from operating income of 447.64 million CNY on revenue of 13.63 billion CNY), which is also below the median for the industry. Geographically, the company is concentrated in China, with no disclosed international revenue segments. Its revenue is primarily derived from a single business line, commodity chemicals, which exposes it to commodity price volatility and cyclical demand. The lack of diversification increases its vulnerability to sector-specific downturns. Looking ahead, the company is expected to see modest revenue growth, though the exact magnitude is not specified. Capital expenditures are expected to remain high, which may continue to pressure free cash flow. The company's operating cash flow of 1.14 billion CNY provides some buffer, but it is not sufficient to cover the large capital outlay. The risk assessment highlights liquidity as a medium concern, with the company's cash and equivalents at just 4.16 million CNY, far below the level needed to cover short-term obligations. The risk of dilution is currently low, but the company's capital structure includes long-term debt of 16.15 billion CNY, which could necessitate future equity issuance if debt service becomes burdensome. Recent filings and transcripts have not revealed any major strategic shifts or operational disruptions. The company remains focused on its core chemical production business, with no significant new product launches or market expansions disclosed in the latest available data.
Key takeaways
  • The company has a weak ROE and ROA, indicating poor capital efficiency and asset utilization.
  • High capital expenditures are straining free cash flow, which is significantly lower than the amount invested in long-term assets.
  • The company's liquidity position is constrained, with minimal cash reserves and a negative net cash position after debt.
  • Revenue is concentrated in a single business line and geographic region, increasing exposure to sector-specific and regional risks.
  • Analysts are cautiously optimistic, with a mean recommendation of 1.67 and a wide range of price targets.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$13.63B
Gross profit$2.26B
Operating income$447.6M
Net income$142.5M
R&D
SG&A
D&A
SBC
Operating cash flow$1.14B
CapEx-$1.73B
Free cash flow$253.2M
Total assets$48.75B
Total liabilities$23.28B
Total equity$25.47B
Cash & equivalents$4.2M
Long-term debt$16.15B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$13.63B$447.6M$142.5M$253.2M
FY-1$10.16B-$841.9M-$556.3M-$3.63B
FY-2$12.04B$3.03B$2.53B-$4.41B
FY-3$12.59B$4.76B$4.00B-$571.2M
FY-4$7.98B$3.22B$2.72B-$695.1M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$48.75B$25.47B$4.2M
FY-1$47.20B$24.47B$1.9M
FY-2$47.20B$26.93B
FY-3$38.62B$17.73B$37.4k
FY-4$26.12B$13.83B$1.4M
PeriodOCFCapExFCFSBC
FY0$1.14B-$1.73B$253.2M
FY-1$1.16B-$2.86B-$3.63B
FY-2$2.67B-$7.82B-$4.41B
FY-3$503.6M-$5.26B-$571.2M
FY-4$1.42B-$4.00B-$695.1M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$3.91B$352.3M$260.3M
FQ-1$4.09B$393.2M$228.9M
FQ-2$3.78B$121.9M$6.8M
FQ-3$3.03B-$77.1M-$119.1M
FQ-4$2.73B$16.0M$26.0M
FQ-5$2.70B-$1.32B-$999.8M
FQ-6$2.68B$210.9M$152.5M
FQ-7$2.46B$105.1M$132.9M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$48.55B$25.58B$2.89B
FQ-1$48.75B$25.47B$4.2M
FQ-2$48.00B$24.78B$2.45B
FQ-3$48.24B$24.79B$1.9M
FQ-4$47.75B$24.63B$2.84B
FQ-5$47.20B$24.47B$1.9M
FQ-6$48.39B$25.65B$2.67B
FQ-7$49.06B$25.49B
PeriodOCFCapExFCFSBC
FQ0$206.7M-$202.7M
FQ-1$1.14B-$1.73B
FQ-2$877.3M-$1.03B
FQ-3$210.3M-$768.5M
FQ-4$124.3M-$442.1M
FQ-5$1.16B-$2.86B
FQ-6$2.30B-$4.94B
FQ-7$1.55B-$2.21B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$25.47B
Net cash-$16.15B
Current ratio
Debt/Equity0.6
ROA0.3%
ROE0.6%
Cash conversion8.0%
CapEx/Revenue-12.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric002812Activity
Op margin3.3%0.4% medp25 -8.0% · p75 16.0%above median
Net margin1.0%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin16.6%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-12.7%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity63.0%59.0% medp25 54.9% · p75 72.9%above median
Observations
IR observations
Mean price target62.52 CNY
Median price target58.15 CNY
High price target85.00 CNY
Low price target32.00 CNY
Mean recommendation1.67 (1=strong buy, 5=strong sell)
Strong-buy count7.00
Buy count6.00
Hold count2.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate1.57 CNY
Last actual EPS0.15 CNY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-01 11:37 UTC#364236a3
Source: analysis-pipeline (hybrid)Generated: 2026-05-01 11:38 UTCJob: 7dadef97